Andropause, androgen therapy and prostate safety
Aging Male, ISSN: 1368-5538, Vol: 2, Issue: 2, Page: 81-86
1999
- 8Citations
- 4Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
There is indisputable evidence that advancing age is associated with a decline in the production of several hormones. The most prominent alterations are related to the sex steroids, but other hormones such as growth hormone and melatonin are also profoundly affected. The clinical syndrome of androgen decline in the aging male, or andropause, has been described, but a direct causality between its manifestations and the alterations in a specific hormone is not yet fully established. Concerns exist about the effect of exogenous androgens in various organ systems. The most serious refer to the prostate in general and the development of carcinoma in particular. Current evidence indicates that, with the exception of severe lower urinary tract obstructive symptoms or prostate cancer, the use of androgens is safe. However, experience with chronic androgen administration in the elderly is still limited and caution is needed. Prostate assessment by digital rectal examination and measurement of prostate-specific antigen are mandatory prior to and during treatment. Careful, long-term monitoring must be a serious commitment by both the patient and the physician. A set of general recommendations for androgen supplementation in the aging male is included, with emphasis on prostate safety issues regarding lower urinary tract obstructive symptoms and prostate cancer.
Bibliographic Details
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know